An armed oncolytic measles vaccine virus eliminates human hepatoma cells independently of apoptosis

Chemovirotherapy for head and neck squamous cell carcinoma with EGFR-targeted and CD/UPRT-armed oncolytic measles virus

(2011) K Zaoui et al.   CANCER GENE THERAPY

Effect of a caspase inhibitor, zVADfmk, on the inhibition of breast cancer cells by herpes simplex virus type 1

(2011) L W Wood et al.   CANCER GENE THERAPY

Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer

(2010) E. Galanis et al.   CANCER RESEARCH

Use of attenuated paramyxoviruses for cancer therapy

(2010) Patrycja J Lech et al.   Expert Review of Vaccines

Mantle cell lymphoma salvage regimen: synergy between a reprogrammed oncolytic virus and two chemotherapeutics

(2010) G Ungerechts et al.   GENE THERAPY

Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting

(2010) Melanie B. Thomas et al.   JOURNAL OF CLINICAL ONCOLOGY

Central and peripheral nervous system toxicity of common chemotherapeutic agents

(2008) Chrissa Sioka et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Heat shock protein inhibitors increase the efficacy of measles virotherapy

(2008) C Liu et al.   GENE THERAPY

Gene therapy progress and prospects cancer: oncolytic viruses

(2008) T-C Liu et al.   GENE THERAPY

Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded

(2008) Roberto Cattaneo et al.   NATURE REVIEWS MICROBIOLOGY